What is NDC 62032-913?

62032-913 is the product NDC for Obagi Nu-Derm System Normal-Dry Skin Transformation Trial kit, listed with the FDA by Obagi Cosmeceuticals LLC.

What drug is associated with this NDC?

Obagi Nu-Derm System Normal-Dry Skin Transformation Trial (Hydroquinone, Homosalate, Octisalate, Zinc oxide).

Obagi Cosmeceuticals LLC, NDC labeler code 62032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Obagi Nu-Derm System Normal-Dry Skin Transformation Trial?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 62032-913

NDC codes

FDA NDC Directory

Product NDC (as listed)62032-913Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62032-0913Add the package segment from the table below.

Product information

Brand name (proprietary): Obagi Nu-Derm System Normal-Dry Skin Transformation Trial
Generic name (nonproprietary): hydroquinone, homosalate, octisalate, zinc oxide
Dosage form: Kit
Labeler: Obagi Cosmeceuticals LLCNDC labeler code 62032
Product type: Over-the-counter drug
Marketing category: Unapproved drug (other)
Marketing start: Dec 2, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 62032-913_f1292c32-db82-4875-b681-b984c56f9cffSPL ID f1292c32-db82-4875-b681-b984c56f9cffSPL set ID e2c23345-69df-47a1-8e6b-b6225080d363RxCUI 197795

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Product label

Current FDA label (SPL), effective Oct 23, 2025.

Indications (excerpt from the label)

Uses helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62032-913

What is NDC 62032-913?: 62032-913 is the product NDC for Obagi Nu-Derm System Normal-Dry Skin Transformation Trial kit, listed with the FDA by Obagi Cosmeceuticals LLC.
What drug is associated with this NDC?: Obagi Nu-Derm System Normal-Dry Skin Transformation Trial (Hydroquinone, Homosalate, Octisalate, Zinc oxide).
Who is the labeler?: Obagi Cosmeceuticals LLC, NDC labeler code 62032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Obagi Nu-Derm System Normal-Dry Skin Transformation Trial?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Obagi Nu-Derm System Normal-Dry Skin Transformation Trial NDC 62032-913